Skip to main content
. 2004 Mar;57(3):253–262. doi: 10.1046/j.1365-2125.2003.02004.x

Table 3.

Adverse events reported by both adult and paediatric patients (percent with symptom) on admission (day 0) and during the whole of the 28-day follow-up period

Patients with symptom (%)
Symptom Day 0 (n = 85) Post-treatment (n = 83)1
Headache 55% 36%
Dizziness 24% 14%
Abdominal pain 12% 11%
Anorexia 15%  1%
Nausea 14%  4%
Tinnitus  8%  6%
Deafness  5%  2%
Palpitations  0%  1%
Insomnia  2%  1%
1

Two patients lost to follow-up.